A Study to Compare Insulin Intensification of Biphasic Insulin Aspart 30 and Insulin Analogues (Insulin Glargine and Insulin Aspart) in Insulin naïve Type 2 Diabetic Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 335 participants.
Also called NCT02453685
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 335 participants
- Sponsor
- Registry
-
NCT02453685 -
2014-003708-62
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Australia, Bulgaria, Hungary, India, Serbia, South Korea, Thailand, Türkiye, United Arab Emirates
- Registry status
- Completed
Technical summary
Registry record NCT02453685. Randomized; no masking; primary purpose treatment. Start 2015-08-31 (actual); primary completion 2016-09-20 (actual). Results posted on 2019-02-08.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Compare Insulin Intensification of Biphasic Insulin Aspart 30 and Insulin Analogues (Insulin Glargine and Insulin Aspart) in Insulin naïve Type 2 Diabetic Patients
- Condition
- Diabetes
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- biphasic insulin aspart 30
- Intervention (Drug)
- insulin glargine
- Intervention (Drug)
- insulin aspart
- Lead sponsor
- Novo Nordisk A/S
Record details
- Record id
cardio:ct-nct02453685- Content hash
5e9d2a871f8b0c6ba9e5963f16478fabab74d460ca0de5a8b9cb61821222f470